Today Scorpions – Tomorrow Pit Vipers and Spiders
By Tom Wall
Friday, August 5, 2011
Rare Disease Therapeutics Inc., a Franklin, Tenn.-based company focused on developing orphan products, has won FDA approval for Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the U.S.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.